NFKB1 and acute myeloid leukemia: NEDD8-dependent ubiquitin ligases regulate NF-κB activity, and their inhibition by MLN4924 in AML cells results in reduced binding of NF-κB to the miR-155HG promoter and a reduction in miR-155 expression.